ANRAnatara Lifesciences Ltd

ANR Stock Price, Valuation & Chart | Anatara Lifesciences Ltd

Compare

$0.010+0.00 (+11.11%)

At close · 01 Sept 2026, 02:31 am

Sector: Healthcare ANR intrinsic value ANR calculated fair value vs price Website

Overview Financials Dividends Ratios

ANR Historical price chart

ANR Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization2.08M

PE Ratio-1.25

EPS-0.01

Trading Volume500.98K

Today's High/Low0.01/0.01

Dividend Yield0.00

52 Week High/Low0.02/0.01

Shares Outstanding207.92M

ANR Financial Statement

ANR Analyst ratings

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Based on 2 analysts giving stock ratings to ANR in the past 3 months.

ANR Analysis & performance metrics

ANR Company profile

Anatara Lifesciences Limited engages in the research, development, and commercializing of evidence-based solutions for gastrointestinal diseases in animals and humans in…

Anatara Lifesciences Limited engages in the research, development, and commercializing of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human…

ANR Management team

Name

Position

David Lionel Brookes F.A.C.I.D., FACRRM, FAICD, MBBS

Executive Chairman & MD

Hayley van der Meer B Biomed Sc, Grad Dip Marketing Management

Commercial Manager

Jonathan Lindh

Company Secretary

John Michailidis B.Sc., EMBA, M.A.I.C.D.COO

Chief Operating Officer & Executive Director

Simon Erskine

Chief Development Officer

Name

Position

David Lionel Brookes F.A.C.I.D., FACRRM, FAICD, MBBS

Executive Chairman & MD

Hayley van der Meer B Biomed Sc, Grad Dip Marketing Management

Commercial Manager

Jonathan Lindh

Company Secretary

John Michailidis B.Sc., EMBA, M.A.I.C.D.COO

Chief Operating Officer & Executive Director

Simon Erskine

Chief Development Officer

Management Team

David Lionel Brookes F.A.C.I.D., FACRRM, FAICD, MBBS

Executive Chairman & MD

Hayley van der Meer B Biomed Sc, Grad Dip Marketing Management

Commercial Manager

Jonathan Lindh

Company Secretary

John Michailidis B.Sc., EMBA, M.A.I.C.D.COO

Chief Operating Officer & Executive Director

Simon Erskine

Chief Development Officer

Management

David Lionel Brookes F.A.C.I.D., FACRRM, FAICD, MBBS

Executive Chairman & MD

Hayley van der Meer B Biomed Sc, Grad Dip Marketing Management

Commercial Manager

Jonathan Lindh

Company Secretary

John Michailidis B.Sc., EMBA, M.A.I.C.D.COO

Chief Operating Officer & Executive Director

Simon Erskine

Chief Development Officer

Total 5 executives

ANR Frequently asked questions

What is Anatara Lifesciences Ltd (ANR) Stock Price?

Current stock price of Anatara Lifesciences Ltd (ANR) stock is $0.010. The stock price is +11.11% higher in the session. The intraday range can be seen from this page. Volume of Anatara Lifesciences Ltd (ANR) stock is 500.98K.

Last updated at 01 Sept 2026, 02:31 am.

Why is the Anatara Lifesciences Ltd (ANR) stock price going up or down today?

The stock price of Anatara Lifesciences Ltd (ANR) can change with earnings, company news, and overall market sentiment. Anatara Lifesciences Ltd operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Anatara Lifesciences Ltd stock expensive at its current price?

Whether Anatara Lifesciences Ltd looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ANR on this page is -1.25. EPS on this page is -0.01. Compare those figures with peers and growth expectations before deciding if the current Anatara Lifesciences Ltd price is justified.

How has the stock price of Anatara Lifesciences Ltd (ANR) performed historically?

Historical performance for Anatara Lifesciences Ltd (ANR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ANR reacted to past earnings and market events.

Should I buy Anatara Lifesciences Ltd (ANR) stock, at this price?

Buying Anatara Lifesciences Ltd (ANR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.